SUMMARY Recent studies have shown that the sodium conductance of the sarcolemma is disturbed in paramyotonia. Tocainide is a new antiarrhythmic agent which seems to reduce effectively sodium conductance. Eight patients with paramyotonia were treated with tocainide, whereby the paramyotonic stiffness and weakness brought about by cooling could be prevented.
Paramyotonia congenita is a dominantly inherited disease. The course is non-progressive. ' The patients experience an increasing muscle stiffness in a cold environment, especially when muscle effort is involved. Cooling may produce severe weakness which improves only very slowly, often taking several hours. Mainly the hands and face are affected. No effective medication has been described; the patients could only endeavour to keep themselves warm.
More recent studies have led to the supposition that in paramyotonia a dysfunction of the sodium channels of the sarcolemma is present. This is supported by the following observations: when a paramyotonic muscle is cooled from 37°C down to 320-300C a dense spontaneous activity of muscle fibre action potentials is registered in the electromyogram. This activity will disappear when the cooling is continued down to about 28°-26'C. The 12 17 Over four to six days seven patients were given oral tocainide 400 mg three times a day.
One 78-year-old patient (case 2) received tocainide for only one day. Before treatment and four hours after the last dose of tocainide the force of each patient's fist closure was measured under isometric conditions. The patients were asked to make a fist repeatedly 15 times and press the fingers maximally on a metal plate which was connected to the force transducer. The closing and opening of the fingers was also registered mechanographically.2 From these recordings the maximal force, the time to threequarters relaxation, and the time to half-way opening of the closed fingers were measured later for each contraction. The temperature was measured in the flexor digitorum communis muscle. The studies were done at a muscular temperature of 37°-36°C and at 32°-31°C after cooling the hand and forearm in water. Cooling was carried out within 30 minutes.
Results
The patients were treated during the cold time of the year. As early as the second day they, noticed an improvement in their complaints. When taking walks stiffness in the face and hands no longer occurred. After three to four days work outside in cool weather could be undertaken for longer periods without the hands becoming weak. The effect of medication was most impressive for the patients of family 3. Their considerable muscular stiffness which appeared after cooling even without prolonged muscular effort had completely disappeared. One patient (case 6) was able to eat ice cream for the first time in her life without her tongue stiffening.
The figure shows the complete results in case 1. After cooling down to 310C a distinct weakness was apparent after 15 repetitive maximal contractions. The time to three-quarters relaxation of the muscle was prolonged and the opening of the fingers became slower (paradoxical myotonia). After the 9th contraction the closed fist could no longer be opened. Under The beneficial effect of tocainide in paramyotonia is surprising. Dengler and RMdel,' found a good antimyotonic effect in vitro in chemically induced myotonia. However, other antiarrhythmic agents such as procainamide or phenytoin, which bring about a certain improvement in myotonia congenita (Thomsen) showed no effect in paramyotonia. Tocainide apparently works more specifically in paramyotonia than in myotonia congenita (unpublished data). We propose the following explanation: one of the main effects of antiarryhthmic agents is that the sodium conductance of the cell membrane is blocked. This effect seems to be more distinct with tocainide. In myotonia congenita the chloride conductance of the sarcolemma is reduced." Therefore, drugs which mainly affect the sodium channel have only an indirect influence in myotonia congenita. In some cases of paramyotonia the chloride conductance of the sarcolemma is reduced, whereas in other cases it is not measurably altered.' However, the specific effect of tetrodotoxin already discussed above points to a basic disturbance of the sodium channel in paramyotonia. We must assume 'that the sodium conductance of the sarcolemma increases by cooling. In this way a progressing membrane depolarisation takes place. The raised intracellular sodium could then interfere with the calcium reuptake into the sarcoplasmic reticulum after a muscular contraction.14 This would explain the stiffness. In this hypothesis the normalisation of the increased sodium conductance by tocainide would explain why the stiffness as well as the weakness is prevented by tocainide treatment.
What could be the nature of the defect of the sodium channel in paramyotonia? The voltagedependent changes in the ionic conductances normally are brought about by structural rearrangements within the ion channels. The cause of the abnormal ionic conductance could lie in a change in the steric configuration brought about by a temperature dependent alteration of the large protein molecules which are believed to be ion channels. A minor change of genetic origin in the sequence of aminoacids could lead to such a defect. Another possibility would be a disturbance of fluidity of the sarcolemma due to a genetically caused change in the composition of the membrane phospholipids. This would impair the mobility of the channel proteins which probably must come into contact with one another for certain functions. With the conception oif disturbed membrane fluidity a better explanation is given on why the chloride conductance in paramyotonia can apparently be also disturbed in a very variable extent. Kuhn"5 reported that in dominant myotonia congenita (Thomsen) a change in the composition of fatty acids can be present. Butterfield,"6 was able to detect a disturbance of the membrane fluidity by electron spin resonance in myotonia congenita. Such studies in paramyotonia are not yet available.
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